Press Release

Clinical Trial Re-Confirms Role of Oral Bacteriotherapy in Hospitalized Covid-19 Patients

Lausanne, Switzerland, January 20, 2021 — Ormendes is proud to announce the results, now published in Frontiers in Nutrition, of an Italian retrospective clinical study confirming reduced mortality of hospitalized COVID-19 patients with severe pneumonia when supplemented with Sivomixx^®800. 

Bacteriotherapy shows promise as a complementary therapeutic strategy to avoid the progression of COVID-19

Lausanne, Switzerland, July 8th 2020 — Ormendes SA is proud to announce that Sivomixx^®800, one of its probiotic formulations has been used in a clinical study to supplement Covid-19 patients in addition to their standard care, the results of which have now been published in Frontiers in Medicine.